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We studied 455 consecutive episodes of Klebsiella 
pneumoniae bacteremia occurring in 7 countries. Commu-
nity-acquired pneumonia and an invasive syndrome of liver 
abscess, meningitis, or endophthalmitis occurred only in 
Taiwan and South Africa. Infections by K1 and K2 capsular 
serotype, the mucoid phenotype, and aerobactin production 
were important determinants of virulence. The mucoid phe-
notype was seen in 94% of isolates in patients with com-
munity-acquired pneumonia and in 100% of isolates that 
caused the invasive syndrome in Taiwan and South Africa, 
compared with only 2% of isolates elsewhere. Mortality of 
mice injected with mucoid strains (69%) was strikingly higher 
than that occurring in mice injected with nonmucoid strains 
(3%, p<0.001). Differences in clinical features of bacteremic 
infection with K. pneumoniae are due to the virulence fac-
tors expressed by the organism.
I
n the past decade, geographic differences have been rec-
ognized in the spectrum of disease caused by Klebsiella 
pneumoniae. These differences include a preponderance of 
severe invasive disease in Taiwan and other parts of Asia 
(1–8). A characteristic syndrome has emerged in which 
liver abscess is accompanied by K. pneumoniae bactere-
mia and sometimes by endophthalmitis or meningitis. This 
is typically a community-acquired infection that occurs in 
patients with diabetes mellitus. Reports of this syndrome 
from North America, Europe, and Australia are uncom-
mon (2).
Additionally, K. pneumoniae has long been recognized 
as a possible cause of community-acquired pneumonia. 
Over the past 2 decades, K. pneumoniae has been an ex-
ceedingly rare cause of community-acquired pneumonia 
in North America, Europe, and Australia (2,9,10). Yet, it 
remains an important cause of severe community-acquired 
pneumonia in Asia and Africa (11–15). In these regions, 
patients also have classic risk factor of alcoholism (2).
We have completed a prospective study of 455 pa-
tients from 7 countries with K. pneumoniae bacteremia 
(2). We found that although nosocomial infections with K. 
pneumoniae occurred worldwide, some manifestations of 
community-acquired infection (namely, liver abscess and 
community-acquired pneumonia) were geographically re-
stricted. These manifestations of disease occurred almost 
exclusively in Taiwan and South Africa (2). Potential 
explanations for these geographic differences in clinical 
manifestations include host factors such as rates of diabe-
tes mellitus, alcoholism, access to healthcare, and socio-
economic factors.
Another explanation for these differences is related to 
the organism. In this study, we performed capsular sero-
typing, determined the presence of mucoid phenotype and 
aerobactin production, and assessed lethality in a murine 
model and correlated these in vitro and in vivo results with 
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the clinical manifestation of patients with K. pneumoniae 
bloodstream infections. Our aim was to determine whether 
the different manifestations of infection occurring in differ-




A prospective, observational study of consecutive, se-
quentially encountered patients with K. pneumoniae bacte-
remia was conducted in 12 hospitals in the United States, 
Taiwan, Australia, South Africa, Turkey, Belgium, and 
Argentina. No patients were excluded from analysis. The 
study period was January 1, 1996, to December 31, 1997. 
Patients >16 years of age with positive blood cultures for 
K. pneumoniae were enrolled and completed a 188-item 
study form. Patients were followed up for 1 month after 
the onset of bacteremia to assess clinical outcome, includ-
ing deaths and infectious complications. The study was ob-
servational in that administration of antimicrobial agents 
and other therapeutic management were controlled by the 
patient’s physician, not the investigators. The study was 
approved by institutional review boards as required by lo-
cal hospital policy.
Deﬁ  nitions
Terms were deﬁ  ned a priori (that is, before data analy-
sis). Community-acquired bacteremia was deﬁ  ned as a pos-
itive blood culture taken on admission or within 48 hours 
of admission. Site of infection accompanying the bactere-
mia was determined as pneumonia, urinary tract infection, 
meningitis, incisional wound infection, other soft tissue in-
fection, intraabdominal infection, and primary bloodstream 
infection by using Centers for Disease Control and Preven-
tion deﬁ  nitions (16). “Invasive” infections accompanying 
K. pneumoniae bacteremia were further deﬁ  ned as liver 
abscess, meningitis, or endophthalmitis. Liver abscess was 
deﬁ  ned by the coexistence of blood cultures positive for K. 
pneumoniae and evidence of an intrahepatic abscess cavity 
by ultrasonography or computed tomography. Meningitis 
was deﬁ  ned as culture of K. pneumoniae from the cerebro-
spinal ﬂ  uid. Endophthalmitis was deﬁ  ned as decreased vi-
sual acuity, pain, hypopyon, or severe anterior uveitis con-
current with K. pneumoniae bacteremia in a patient.
Microbiology
Blood culture isolates of K. pneumoniae were sent 
by the participating hospitals on nutrient agar slants to the 
Special Pathogens Laboratory in Pittsburgh. There, the 
identity of each isolate as K. pneumoniae was conﬁ  rmed 
by using the Vitek GNI system (bioMérieux Vitek, Hazel-
wood, MO, USA).
The isolates were classiﬁ   ed phenotypically as mu-
coid or nonmucoid. Colonies were touched with a loop; 
the loop was then lifted vertically from the surface of the 
agar plate. Mucoid phenotype was deﬁ  ned as being present 
when a stringlike growth was observed to attach to the loop 
as it was lifted from the plate (Figure 1). Presence of the 
rmpA gene (rmp = regulator of the mucoid phenotype) was 
sought by DNA dot blot hybridization by using a 640-bp 
probe (position 478–1117 of the rmpA gene; accession no. 
X17518). The probe was produced by direct digoxigenin 
(DIG)-labeled PCR by using the PCR DIG probe synthesis 
kit (Roche Diagnostics, Basel, Switzerland) and the prim-
ers Kleb_MP_F1 (5′-GAG CAA AGT TAC TGT TTC 
TAT GGA-3′) and Kleb_MP-R1 (5′-TGA GCC ATC TTT 
CAT CAA CC-3′) on the K. pneumoniae strain B 5055. Dot 
blot hybridization was performed according to the manu-
facturer’s protocol on Hybond N+ nylon membranes (Am-
ersham, Pharmacia Biotech, Piscataway, NJ, USA), and the 
hybridized probe was visualized by using the DIG nucleic 
acid detection kit (Roche Diagnostics).
Capsular K serotyping was performed at the World 
Health Organization International Escherichia and Kleb-
siella Reference Centre (Copenhagen, Denmark) by us-
ing standard methods. In brief, K-typing was conducted 
by counter current immunoelectrophoresis (CCIE) with a 
modiﬁ  ed version of the method described by Palfreyman 
(17). An extract was used as antigen instead of a whole cell 
suspension; the extract use was a modiﬁ  cation because it 
was only heated once for 1 h at 100°C before centrifuga-
tion (18). All isolates with negative or doubtful reactions in 
CCIE were investigated by the classic Quellung technique, 
and K-type nontypeable isolates were investigated for the 
presence (K+) or absence (K–) of a visible capsule by wet 
Figure 1. Mucoid phenotype of Klebsiella pneumoniae. When 
colonies were touched with a loop and the loop lifted vertically from 
the surface of the agar plate, mucoid isolates adhered to the loop 
as it was lifted from the plate. (Figure ﬁ  rst presented at the 36th 
annual conference of the Infectious Diseases Society of America, 
Denver, Colorado, USA, 1998.)RESEARCH
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mount microscopy with India ink. Lipopolysaccharide O 
typing was performed by a previously described inhibition 
ELISA (19).
Aerobactin production was demonstrated by a cross-
feeding bioassay that used Escherichia coli strain LG 1522 
(20). The clinical isolates were grown overnight in M9 
broth containing the iron chelator 2-2′ dipyridyl. Strains 
were spotted onto hardened dipyridyl minimal agar plates. 
After 18 hours’ incubation at 37°C, satellite growth of the 
indicator strain LG 1522 around the spots indicated aero-
bactin production.
Lethality in Mice
A standard inoculum of 1–2 × 107 bacteria in the loga-
rithmic phase of growth from blood culture isolates from 
each study site was injected intravenously into the tail vein 
of C57/BL6J black, female mice, 8–12 weeks old. Two 
mice (Jackson Laboratories, Bar Harbor, ME, USA) were 
inoculated with each strain. Mortality of the mice was ob-
served at 24 hours postinjection. The animal experiments 
were approved by the Institutional Review Board of the 
Veterans Affairs Medical Center, Pittsburgh, Pennsylva-
nia, USA.
Pulsed-Field Gel Electrophoresis (PFGE)
The genotypic relationships of K. pneumoniae blood-
stream isolates were determined by using PFGE. PFGE was 
performed by means of the CHEF-DR II system (Bio-Rad, 
Richmond, CA, USA) with use of the restriction endonu-
clease Xba I (New England Biolabs, Beverly, MA, USA). 
DNA was subjected to electrophoresis for 22 hours at 14°C 
in a 1% agarose gel at 6 V/cm with a linear gradient pulse 
time of 5–35 seconds. The gels were analyzed by using the 
Gel Doc 2000 software (Bio-Rad).
Statistics
Patient demographics and laboratory data were entered 
into PROPHET Statistics version 6.0 (AbTech Corpora-
tion, Charlottesville, VA, USA). The χ2 or Fisher test was 
used to compare categorical variables. Continuous vari-
ables were compared by using the t test or the Mann-Whit-
ney test. Multivariate analysis was used to determine which 
risk factors for mouse lethality by univariate analysis were 
independently signiﬁ  cant.
Results
Serotypes of K. pneumoniae Bacteremic Strains
During the study period, 455 episodes of K. pneu-
moniae bloodstream infection occurred; 141 community-
acquired bloodstream isolates were available and were 
tested for K serotype. Three isolates were not encapsulated, 
and 20 were nontypeable. Forty-seven different capsular 
serotypes were found in the remaining strains; K1 (16%; 
23/141), K2 (11%; 16/141), and K54 (9%; 12/141) were 
the most common serotypes.
One hundred percent (23/23) of K1 serotype strains, 
94% (15/16) of K2 serotype strains, and 100% (12/12) 
of K54 serotype strains were from Taiwan or South Af-
rica. Forty-seven percent (23/49) of isolates from patients 
with community-acquired pneumonia and 50% (7/14) of 
isolates from patients with invasive syndromes possessed 
the K1 or K2 serotype. In comparison, 12% (9/78) isolates 
from patients with other manifestations of community-ac-
quired K. pneumoniae bacteremia had the K1 or K2 sero-
type (p<0.001).
Seventy-three randomly chosen hospital-acquired 
bloodstream isolates from the same multinational study 
were tested for K serotype. One isolate was not encapsu-
lated, and 5 isolates were nontypeable. In contrast to the 
predominance of K1 serotypes in community-acquired in-
fections, 1% (1/75) of hospital-acquired isolates were K1 
(p = 0.0015). The percentage of K2 serotypes in hospital 
acquired isolates (9%, 7/75) was similar to that observed 
in community-acquired isolates (11%, 16/141) (p = 0.76). 
The hospital-acquired K1 isolate was from Taiwan; 4 hos-
pital-acquired K2 isolates were from Africa, 2 were from 
the United States, and 1 was from Taiwan. In contrast to 
the predominance of K1 and K2 serotypes in community-
acquired pneumonia (47%, 23/49 isolates), these serotypes 
were signiﬁ  cantly less likely to occur in nosocomial pneu-
monia (11%, 2/18 cases; p = 0.022).
Relationship between Capsular Serotype 
and Lethality in Mice
When community-acquired strains only were exam-
ined, highest lethality was observed with strains of K1 se-
rotype (mouse deaths 65%) and K2 serotype (mouse deaths 
81%). In contrast, lethality for community-acquired strains 
of other serotypes was signiﬁ   cantly lower (23% died; 
p<0.001). The proportion of deaths in mice injected with 
community-acquired strains of serotype K54 was 9%.
When hospital-acquired strains were examined, mouse 
mortality was only 8%. The only lethal strains were K1 and 
K17 serotypes. None of the 7 hospital-acquired strains of 
serotype K2 proved lethal to mice.
When both community- and hospital-acquired strains 
were assessed together, lethality was signiﬁ  cantly higher 
for strains of K1 (mouse deaths 67%) and K2 serotype 
(mouse deaths 59%) than for strains of other serotype 
(mouse deaths 20%) (p<0.001). The lethality of all strains 
of serotype 54 was 12.5%.
Lipopolysaccharide O Typing
Of 195 isolates which underwent O typing, 30% 
(58/195) were group O1, 17% (34/195) were O2, 8% Klebsiella pneumoniae Infections and Virulence
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(16/195) were O3, 2% (3/195) were O4, 3% (6/195) were 
O5, 1% (2/195) were O2ac, 7% (13/195) were O–, and 
32% (63/195) were O+ but not typable. No strains of O 
group O3, O4, O5, O2ac or O– were lethal to mice. In 
contrast, 21% (12/58) of O1 strains, 26% (9/34) of O2 
strains, and 37% (23/63) of nontypeable O+ strains were 
lethal to mice.
Relationship between Mucoid Phenotype 
and Type of Infection
The mucoid phenotype was observed in 93% (13/14) of 
strains from patients with invasive disease, in 67% (33/49) 
of strains from patients with community-acquired pneumo-
nia, and in 28% (22/78) of strains from patients with other 
sites of community-acquired infection (p<0.001). Mucoid 
strains of community-acquired bacteremic K. pneumoniae 
were exclusively found in Taiwan and South Africa; 56% 
(45/80) and 60% (21/35) of Taiwanese and African strains, 
respectively, were mucoid, whereas no mucoid strains were 
detected in community-acquired bacteremic strains from 
other countries (Table 1). In Taiwan and South Africa, mu-
coid strains predominated in community-acquired strains 
(57%, 66/115) compared with hospital-acquired strains 
(18%, 7/38) (Table 2).
In Taiwan and South Africa, community-acquired 
pneumonia was due to mucoid strains of K. pneumoniae in 
younger patients with no serious underlying disease, while 
nonmucoid strains predominated in older patients and those 
with serious underlying disease (Table 3). In both countries 
combined, 94% (29/31) strains from community-acquired 
pneumonia patients with no serious underlying disease had 
the mucoid phenotype compared to 19% (3/16) strains from 
patients with serious underlying disease (p<0.001). All iso-
lates (13/13) from patients in Taiwan or South Africa with 
the invasive syndrome of liver abscess, meningitis, or en-
dophthalmitis had the mucoid phenotype (Table 4).
The proportion of deaths in mice injected with mucoid 
strains (69% of mice died) was strikingly higher than that 
occurring in mice injected with nonmucoid strains (3% 
mice died) (p<0.001). There was no association between 
human deaths and the presence of a mucoid strain (39% 
died) or a nonmucoid strain (35% died) (p>0.20). In a mul-
tivariate model, increased severity of illness score when 
ﬁ  rst evaluated (p = 0.0001), but not infection with a mucoid 
strain, country of origin, or history of alcoholism (p>0.20 
for all) was associated with human deaths.
Association between Phenotypic Evidence 
of Mucoidity and Presence of rmpA Gene
Phenotypic evidence of mucoidity as judged by the 
deﬁ  nition in the methods section (“a string-like growth ob-
served to attach to the loop as it was lifted from the plate”) 
(Figure 1) was highly correlated with the presence of the 
rmpA gene. Of 77 mucoid isolates, 86% (66/77) were rmpA 
gene positive, and 14% (11/77) were rmpA gene negative. 
Of 137 nonmucoid isolates, 93% (128/137) were negative 
for the rmpA gene and 7% (9/137) were rmpA positive.
Relationship between Aerobactin 
Production and Type of Infection
The presence of the rmpA gene and phenotypic evi-
dence of aerobactin production were closely correlated. 
Ninety-six percent of rmpA gene–positive isolates were 
aerobactin producers; aerobactin was produced by 2% of 
isolates that were rmpA gene–negative.
Associations between aerobactin production and type 
of infection were similar to those between the mucoid phe-
notype and type of infection. Only 6% (4/62) strains from 
patients in countries other than Taiwan and South Africa 
were aerobactin producers. In Taiwan and South Africa, 
66% of patients with community-acquired pneumonia and 
85% of patients with the invasive syndrome had aerobac-
tin-producing strains, in comparison with 42% of patients 
with other community-acquired infections and 16% of pa-
tients with hospital-acquired strains (Table 2).
Relationship between Mucoid Phenotype, 
Capsular Serotype, and Lethality in Mice
When both community-acquired and hospital-acquired 
strains were considered together, 77% (36/47) of isolates of 
Table 1. Disease type by virulence factor* 








mortality rate, %† 
Taiwan
  Community-acquired  28 (22/80)  56 (45/80)  54 (43/80)  46
  Hospital-acquired  17 (2/12)  25 (3/12)  33 (4/12)  29
South Africa 
  Community-acquired  46 (16/35)  60 (21/35)  63 (22/35)  52
  Hospital-acquired  16 (4/25)  16 (4/25)  8 (2/25)  0
Rest of world 
  Community-acquired  4 (1/26)  0 (0/26)  4 (1.26)  0
  Hospital-acquired  5 (2/36)  8 (3/36)  8 (3/36)  0
*Note the virtual absence of putative virulence factors in strains from the rest of the world, other than Taiwan and South Africa. See Results for p values. 
†2 mice were tested for each available strain.  RESEARCH
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serotypes K1 and K2 were found to be mucoid. Of the other 
45 serotypes, 24% (40/167) were mucoid (p<0.001).
However, none of the mice inoculated with nonmu-
coid K1 or K2 serotype strains died, compared with 81% 
of mice inoculated with mucoid K1 or K2 serotype strains 
(p<0.001). Just 4% of mice inoculated with nonmucoid 
strains of serotypes other than K1 or K2 died, compared 
with 44% mice inoculated with mucoid organisms of sero-
types other than K1 or K2 (p<0.001).
When the parameters of mucoid phenotype, serotypes 
K1 and K2, and country of origin were assessed in the 
multivariate model of lethality to mice, mucoid phenotype 
was strongly associated with the death of mice (p = 0.001). 
Presence of serotypes K1 and K2 approached statistical 
signiﬁ  cance (p = 0.05).
PFGE
PFGE was performed on strains of the same serotype. 
Dendrograms of organisms of serotype K1 are shown in 
Figure 2 and dendrograms of serotype K2 in Figure 3.
Discussion
We have been able to evaluate geographic differenc-
es in community-acquired K. pneumoniae infections by 
studying consecutive patients with community-acquired K. 
pneumoniae bacteremia from 7 different countries during 
the same period. It could be hypothesized that patient char-
acteristics are primarily responsible for these differences. 
For example, genetic predilections (susceptibility of Asians 
to liver abscess), underlying diseases (for example, higher 
prevalence of chronic hepatitis B virus infection in Tai-
wan), social factors (different foods or cultural practices), 
and economic factors (for example, access to healthcare, 
antimicrobial drug usage) may be responsible for the dif-
ferent manifestations of serious K. pneumoniae infection 
observed in different regions. Despite these other possibili-
ties, our experimental studies suggest that the differences in 
clinical features arise from differences in the virulence of 
individual microorganisms.
In particular, we found that strains with K1 or K2 sero-
type, strains with a mucoid phenotype, and strains that are 
capable of aerobactin production are rarely found to cause 
substantial infection in patients from study hospitals out-
side Taiwan and South Africa. Strains with such virulence 
characteristics were more likely to cause community-ac-
quired infections than hospital-acquired infections. When 
strains with these virulence characteristics were inoculated 
into mice, deaths exceeded 80% compared with mortality 
rates of <5% in mice inoculated with strains lacking these 
characteristics.
Additionally, by PFGE, we found genetically related 
strains possessing all 3 virulence characteristics (Figures 
2, 3). Taiwanese investigators have debated whether K. 
pneumoniae strains that cause liver abscess in Taiwan 
are clonally related (1,4,6,7,21). Genetic relatedness in 
K. pneumoniae strains that cause community-acquired 
pneumonia has not been previously described. However, 
we have found that genotypically related organisms were 
responsible for bacteremic community-acquired pneumo-
nia due to K. pneumoniae and sometimes both pneumonia 
and liver abscess or meningitis. Whether K. pneumoniae is 
spread from person to person, whether related strains are 
acquired from common sources, or whether virulent strains 
arise from a common ancestor remains to be determined.
Much prominence has been placed in the past on the 
role of capsule in the pathogenesis of K. pneumoniae infec-









mortality rate, %† 
Community-acquired pneumonia  49 (23/47)  68 (32/47)  66 (31/47)  47
Invasive syndrome  54 (7/13)  100 (13/13)  85 (11/13)  82
Other community-acquired  15 (8/55)  38 (21/55)  42 (23/55)  36
Hospital-acquired 16 (6/38)  18 (7/37)  16 (6/38)  7
*Note that strains from patients in Taiwan and South Africa with community-acquired pneumonia or the invasive syndrome (liver abscess, 
endophthalmitis, meningitis) were more likely to have the putative virulence factors than hospital-acquired strains. See Results for p values. 
†2 mice were tested for each available strain.  









mortality rate, %† 
South Africa  50 (12/24)  75 (18/24)  67 (16/24)  58
  No underlying disease  63 (12/19)  89 (17/19)  79 (15/19)  78
  Underlying disease‡  0 (0/5)  20 (1/5)  20 (1/5)  0
Taiwan 48 (11/43)  65 (15/23)  57 (13/23)  35
  No underlying disease  75 (9/12)  100 (12/12)  83 (10/12)  50
  Underlying disease‡  18 (2/11)  18 (2/11)  27 (3/11)  18
*Note that patients with no underlying disease were more likely to be infected by strains with the putative risk factors than were elderly patients or patients 
with serious underlying disease. See Results for p values. 
†2 mice were tested for each available strain. 
‡Underlying disease was defined as presence of end-stage liver or renal failure, metastatic malignancy, neutropenia, or age >70.Klebsiella pneumoniae Infections and Virulence
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tions. Capsular types K1 and K2 have been regarded as par-
ticularly virulent (22). Taiwanese researchers have found 
that serotype K1 is frequently associated with community-
acquired K. pneumoniae bacteremia (3,23). We have also 
conﬁ  rmed that serotypes K1 and K2 occur more frequently 
in isolates from community-acquired infections in Taiwan 
and South Africa than from hospital-acquired isolates in 
these countries or elsewhere (Table 1).
The degree of virulence conferred by a particular K 
antigen may be related to the mannose content of the cap-
sular polysaccharide. Capsular types with high virulence 
in animal models (for example, K2) lack mannose-α-2/3-
mannose structures found in capsular types of lower viru-
lence (24). The mannose-α-2/3-mannose structures are 
recognized by a surface lectin of macrophages, which me-
diate complement and antibody-independent phagocytosis. 
Strains that lack these sequences (for example, those with 
the K2 antigen) may not be recognized by macrophages, 
and hence phagocytosis may not take place. Furthermore, 
surfactant protein A (the main protein component of lung 
surfactant) enhances the phagocytosis by alveolar macro-
phages of strains that bear mannose-α-2/3-mannose struc-
tures in their capsule, but not strains which lack the man-
nose structure (25).
Some strains belonging to the K2 serotype are not as 
virulent as others (26). Thus, factors other than capsule 
may also be important for virulence. Although previous 
authors did not ﬁ  nd any markers for these differences (26), 
we found that mucoid strains of K1 or K2 serotype were 
more virulent to mice than nonmucoid strains of the same 
serotype. No mouse inoculated with nonmucoid K1 or K2 
serotype strains died, compared to 81% mice inoculated 
with mucoid K1 or K2 serotype strains (p<0.001). Mul-
tivariate analysis of variables related to mouse mortality 
rates showed that mucoidity was more closely associated 
with death than was capsular serotype. Contrary to popu-
lar belief, the biochemical nature of the mucoid phenotype 
may be unrelated to capsular polysaccharide but rather 
related to extracapsular polysaccharide (27). A previous 
study has shown that the mucoid phenotype may be due to 
a gene designated rmpA (regulator of mucoid phenotype) 
(28). In another mouse model, a mutant carrying this gene 
was 1,000-fold more virulent than an isolate without the 
gene. Extracellular polysaccharides may protect mucoid 
strains of K. pneumoniae from phagocytosis by neutrophils 
and from serum killing by complements (27).
We found that the mucoid phenotype frequently coex-
ists with aerobactin production. The growth of bacteria in 
host tissues is limited not only by host defense mechanisms 
but also by its supply of available iron. The supply of free 
iron in the host milieu may be extremely low; many bac-
teria attempt to secure their supply of iron in the host by 
secreting high-afﬁ  nity iron chelators called siderophores. 
Aerobactin is a hydroxamate-type siderophore occasion-
ally found in Klebsiella strains. K. pneumoniae strains that 
produce aerobactin were more virulent in our mouse mod-
el, whereas strains not producing this siderophore were less 
likely to be; additionally, patients with severe community-
acquired infection were more likely to be infected by aero-
bactin-producing strains. In another mouse model, transfer 










mortality rate, %† 
Taiwan 50 (6/12)  100 (12/12)  85 (10/12)  81
South Africa  100 (1/1)  100 (1/1)  100 (1/1)  100
*Mucoid strains are highly lethal to mice. 
†2 mice were tested for each available strain. 
Figure  2. Pulsed-ﬁ  eld gel electrophoresis 
of bacteremic Klebsiella pneumoniae 
isolates of serotype K1.RESEARCH
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of a recombinant plasmid harboring the genes for aerobac-
tin and its receptor enhanced the virulence of an otherwise 
avirulent strain by 100-fold (29). The strong association 
found in this study between mucoid phenotype (rmpA posi-
tive isolates) and aerobactin production suggests that the 2 
virulence characteristics might be genetically coupled on 
a large virulence plasmid, as has previously been demon-
strated (28). We have not yet determined which of these 2 
virulence factors is more important.
Strains harboring these virulence factors appear to be 
more frequent in certain geographic regions, and this may 
explain geographic differences in manifestation of com-
munity-acquired  Klebsiella infections. The evolutionary 
genetics of K. pneumoniae have never been explored. To 
our knowledge, we have been the ﬁ  rst to ﬁ  nd clones bear-
ing multiple virulence characteristics that are responsible 
for life-threatening community-acquired K. pneumoniae 
pneumonia in otherwise healthy persons. Investigation into 
the mechanisms of virulence in K. pneumoniae could lead 
to preventive measures (such as vaccination) in high-risk 
parts of the world.
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